SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Frostman who wrote (17826)1/16/1999 11:54:00 PM
From: VLAD  Read Replies (1) of 23519
 
Frostman,

If you clicked on that link that Mike provided and joined (free membership) then you can read the report dated January 10, 1999 which was published by Multex-Stock Review from Ace Consensus estimates.

Note the part that reads:

"Presently a return to profitability is foreseen in 1999, with earnings of $1.06 per share thought PROBABLE."

Let's see now 2 29/32 / 1.06 = 2.74 = forward 12 month PE

So we have a biotech stock which actually has a product and product income and a 1999 forward estimate of over $1.00/share trading under $3.00/share. Just crazy!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News